Click Here for 5% Off Your First Aladdin Purchase!

Mifepristone - ≥98%, high purity , Progesterone receptor antagonist, CAS No.84371-65-3, Progesterone receptor antagonist

  • Moligand™
  • ≥98%
Item Number
M126999
Grouped product items
SKUSizeAvailabilityPrice Qty
M126999-200mg
200mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$46.90
M126999-1g
1g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$151.90
M126999-5g
5g
In stock
$402.90
M126999-25g
25g
In stock
$1,409.90

PR and GR antagonist

Basic Description

Synonymsmifepristone|84371-65-3|Mifegyne|Mifeprex|RU-486|Korlym|RU486|RU 486|RU 38486|Mifepriston|Corlux|RU-38486|Mifepristona|Mifepristonum|Mifepristonum [Latin]|C29H35NO2|HSDB 6841|UNII-320T6RNW1F|BRN 5779404|320T6RNW1F|CCRIS 9332|DTXSID5023322|RU 486-6|CHEBI:5
Specifications & Purity≥98%
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeAGONIST, ANTAGONIST
Mechanism of actionProgesterone receptor antagonist
Product Description

Mifepristone is a remarkably active antagonist of progesterone receptor and glucocorticoid receptor with IC50 of 0.2 nM and 2.6 nM, respectively.
A progesterone and glucocorticoid antagonist, suppresses VEGF production.

Product Properties

ALogP3.8

Associated Targets

NR3C1 Tclin Glucocorticoid receptor 67 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PGR Tclin Progesterone receptor 57 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NR1I2 Tchem Nuclear receptor subfamily 1 group I member 2 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 27 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
INCHI InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1
InChi Key VKHAHZOOUSRJNA-GCNJZUOMSA-N
Canonical SMILES CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O
Isomeric SMILES CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O
WGK Germany 3
RTECS KG2955000
PubChem CID 55245
Molecular Weight 429.59
Reaxy-Rn 5779404

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

9 results found

Lot NumberCertificate TypeDateItem
I2226309Certificate of AnalysisJul 10, 2024 M126999
I2226306Certificate of AnalysisJul 04, 2024 M126999
G2417847Certificate of AnalysisJun 29, 2024 M126999
G2417853Certificate of AnalysisJun 29, 2024 M126999
G2417854Certificate of AnalysisJun 29, 2024 M126999
G2417855Certificate of AnalysisJun 29, 2024 M126999
G2417856Certificate of AnalysisJun 29, 2024 M126999
I2226305Certificate of AnalysisJul 22, 2022 M126999
L2307160Certificate of AnalysisJul 22, 2022 M126999

Chemical and Physical Properties

SolubilitySoluble in water (partly), DMF (~30 mg/ml), ethanol (50 mg/ml), methanol, and DMSO (86 mg/ml at 25 °C).(Soluble): chloroform
SensitivityHeat sensitive
Specific Rotation[α]141° (C=0.5,CHCl3)
Melt Point(°C)195 °C

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS07
Signal Danger
Hazard Statements

H302:Harmful if swallowed

H312:Harmful in contact with skin

H332:Harmful if inhaled

H360:May damage fertility or the unborn child

H362:May cause harm to breast-fed children

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P263:Avoid contact during pregnancy/while nursing.

P203:Obtain, read and follow all safety instructions before use.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P317:Get emergency medical help.

WGK Germany 3
RTECS KG2955000
Reaxy-Rn 5779404
Merck Index 6186

Related Documents

References

1. Shannon S et al..  (2015)  Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells..  PLoS One,  10  (8): (e0135951).  [PMID:26284619]
2. Nair M et al..  (2018)  Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo..  Int J Mol Sci,  19  (2):   [PMID:29443896]
3. Zhang B et al..  (2020)  Corticosteroid receptor rebalancing alleviates critical illness-related corticosteroid insufficiency after traumatic brain injury by promoting paraventricular nuclear cell survival via Akt/CREB/BDNF signaling..  J Neuroinflammation,  17  (318).  [PMID:33100225]
4. Wang C et al..  (2017)  Experimental research on the relationship between the stiffness and the expressions of fibronectin proteins and adaptor proteins of rat trabecular meshwork cells..  BMC Ophthalmol,  17  (268).  [PMID:29284449]
5. Karami Kheirabad M et al..  (2015)  Expression of Melanocortin-4 Receptor mRNA in Male Rat Hypothalamus During Chronic Stress..  Int J Mol Cell Med,  (3): (182-7).  [PMID:26629487]
6. Xiao R et al..  (2016)  Environmental and Genetic Activation of Hypothalamic BDNF Modulates T-cell Immunity to Exert an Anticancer Phenotype..  Cancer Immunol Res,  (6): (488-497).  [PMID:27045020]

Solution Calculators